Hospital of the University of Pennsylvania, Perelman Center for Advanced Medicine is a clinical research site located in Philadelphia, Pennsylvania, United States 19104.
Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.
Hospital of the University of Pennsylvania, Perelman Center for Advanced Medicine has participated in 2 clinical trials with 1 currently active.
Therapeutic areas: HER2-positive Breast Cancer, Metastatic or Unresectable Cutaneous Melanoma.
Sponsors: Seagen, a wholly owned subsidiary of Pfizer, Pfizer.
Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Hospital of the University of Pennsylvania, Perelman Center for Advanced Medicine has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Hospital of the University of Pennsylvania, Perelman Center for Advanced Medicine has 2 clinical trials on record, with 1 currently active. Their work covers HER2-positive Breast Cancer, Metastatic or Unresectable Cutaneous Melanoma.
Hospital of the University of Pennsylvania, Perelman Center for Advanced Medicine has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.